Items tagged with Treatment
MSF responds to TB Alliance announcement of the Nix-TB clinical trial (post)
On 13 May, TB Alliance announced the start of its Nix-TB (New Investigational Drugs for XDR-TB) clinical trial, the first to test a new all-oral regimen for extensively drug-resistant tuberculosis (XDR-TB).
SA hosts world’s first study into better XDR-TB treatment (post)
South African scientists are spearheading the world’s first trial into shorter and better treatment for tuberculosis (XDR-TB), which kills about half of all those diagnosed with the condition in South Africa.
Workshop on use of bedaquiline to treat extensively drug-resistant tuberculosis (XDR-TB) in Belarus (post)
The National Tuberculosis Programme (NTP) in Belarus, in collaboration with WHO and with the support of the United Nations Development Programme; the Global Fund to Fight AIDS, TB and Malaria (the Global Fund); and Médecins Sans Frontières, organized a workshop on "The use of bedaquiline to treat XDR-TB" on 7 May 2015 at the Republican Scientific and Practical Centre for Pulmonology and Tuberculosis in Minsk, Belarus. The training was conducted by WHO and national experts from NTP and the National Pharmacovigilance Centre and was attended by 28 participants.
'Imperfect drug penetration' speeds pathogens' resistance, study finds (post)
SAN FRANCISCO, May 18, 2015 -- Prescribing patients two or more drugs that do not reach the same parts of the body could accelerate a pathogen's resistance to all of the drugs being used in treatment, according to a new study published today in the Proceedings of the National Academy of Sciences.
What needs to be added to South Africa’s anti-TB toolbox (post)
The approval in South Africa last year of the first new TB drug in 50 years was celebrated as a milestone in the fight against the global epidemic.
Impact of decentralized care and the Xpert MTB/RIF test on rifampicin-resistant tuberculosis treatment initiation in Khayelitsha, South Africa (post)
Abstract
SureAdhere Mobile Technology, Inc. founded to tackle medication adherence for tuberculosis (post)
UC San Diego research efforts lead to commercialization of proven mHealth platfor.
South Africa: More than R130 million slated for new TB drugs (post)
In just four years, South Africa has seen a 40-fold increase in health facilities treating drug-resistant tuberculosis (DR-TB) as government pledges more than R130 million for new medicines.
Ukraine has started clinical trials of pretomanid (post)
This was reported on May 28, 2015 during a round table at UKRINFORM agency in Kiev “New treatment regimens for Drug-Resistant TB, based on the newest available drugs” organised by Public Movement “Ukrainians against TB” and the Yanovsky National TB Institute, by head of the TB Institute Department of Chemo-resistant TB Svetlana Cherenko.
Page 12 of 108 · Total posts: 0
←First 11 12 13 Last→